NYSE ARCA | ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index.
The underlying index is comprised of qualified income paying securities that are screened for superior company quality and financial health as determined by Morningstar, Inc.'s proprietary index methodology.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| XOM | Exxon Mobil Corp | Energy | Oil & Gas Integrated | 10.00% |
| CVX | Chevron Corp | Energy | Oil & Gas Integrated | 7.01% |
| VZ | Verizon Communications Inc | Communication Services | Telecom Services | 6.33% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 6.08% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.14% |
| T | AT&T Inc | Communication Services | Telecom Services | 4.61% |
| PM | Philip Morris International Inc | Consumer Defensive | Tobacco | 4.57% |
| CSCO | Cisco Systems Inc | Technology | Communication Equipment | 4.11% |
| MO | Altria Group | Consumer Defensive | Tobacco | 3.85% |
| KO | The Coca-Cola Company | Consumer Defensive | Beverages - Non-Alcoholic | 3.66% |
| PEP | PepsiCo Inc | Consumer Defensive | Beverages - Non-Alcoholic | 3.64% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.60% |
| IBM | International Business Machines | Technology | Information Technology Services | 3.37% |
| CMCSA | Comcast Corp | Communication Services | Telecom Services | 2.73% |
| WFC | Wells Fargo & Company | Financial Services | Banks - Diversified | 2.70% |
| TXN | Texas Instruments Incorporated | Technology | Semiconductors | 2.58% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.45% |
| COP | ConocoPhillips | Energy | Oil & Gas E&P | 2.19% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 1.85% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.75% |